Clinical, endocrinological, and molecular characterization of Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism: a single center experience
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: Isolated gonadotropin-releasing hormone (GnRH) deficiency (IGD) is classified as Kallmann syndrome (KS) with anosmia and normosmic idiopathic hypogonadotropic hypogonadism (nIHH). This study was undertaken to investigate the clinical, endocrinological, and molecular characteristics in Korean patients with KS and nIHH. Methods: Twenty-six patients from 25 unrelated families were included. Their clinical, endocrinological, and radiological findings were analyzed retrospectively. Mutation analysis of the GNRH1, GNRHR, KISS1, KISS1R, PROK2, PROKR2, TAC3, TACR3, FGF8, FGFR1, and KAL1 genes was performed in all patients. CHD7 and SOX10 were analyzed in patients with CHARGE (Coloboma, Heart defects, choanae Atresia, Growth retardation, Genitourinary abnormality, Ear abnormality) features or deafness. Results: Of the 26 patients, 16 had KS and 10 had nIHH. At diagnosis, mean chronologic age was 18.1 years in males and 18.0 years in females; height SDS were –0.67±1.35 in males, –1.12±1.86 in females; testis volume was 2.0±1.3 mL; and Tanner stage was 1.5. There were associated anomalies in some of the KS patients: hearing loss (n=6) and congenital heart disease (n=4). Absence or hypoplasia of the olfactory bulb/sulci was found in 84.62% of patients with KS. Molecular defects in KAL1, SOX10, and CHD7 were identified in 5 patients from 4 families (16.0%, 4/25 pedigrees). After sex hormone replacement therapy, there were improvement in sexual characteristics and the sexual function. Conclusion: This study described the clinical, endocrinological, and molecular genetic features in IGD patients in Korea. Although the mutation screening was performed in 10 genes that cause IGD, molecular defects were identified in relatively small proportions of the cohort.
Abstract
Purpose: Isolated gonadotropin-releasing hormone (GnRH) deficiency (IGD) is classified as Kallmann syndrome (KS) with anosmia and normosmic idiopathic hypogonadotropic hypogonadism (nIHH). This study was undertaken to investigate the clinical, endocrinological, and molecular characteristics in Korean patients with KS and nIHH. Methods: Twenty-six patients from 25 unrelated families were included. Their clinical, endocrinological, and radiological findings were analyzed retrospectively. Mutation analysis of the GNRH1, GNRHR, KISS1, KISS1R, PROK2, PROKR2, TAC3, TACR3, FGF8, FGFR1, and KAL1 genes was performed in all patients. CHD7 and SOX10 were analyzed in patients with CHARGE (Coloboma, Heart defects, choanae Atresia, Growth retardation, Genitourinary abnormality, Ear abnormality) features or deafness. Results: Of the 26 patients, 16 had KS and 10 had nIHH. At diagnosis, mean chronologic age was 18.1 years in males and 18.0 years in females; height SDS were –0.67±1.35 in males, –1.12±1.86 in females; testis volume was 2.0±1.3 mL; and Tanner stage was 1.5. There were associated anomalies in some of the KS patients: hearing loss (n=6) and congenital heart disease (n=4). Absence or hypoplasia of the olfactory bulb/sulci was found in 84.62% of patients with KS. Molecular defects in KAL1, SOX10, and CHD7 were identified in 5 patients from 4 families (16.0%, 4/25 pedigrees). After sex hormone replacement therapy, there were improvement in sexual characteristics and the sexual function. Conclusion: This study described the clinical, endocrinological, and molecular genetic features in IGD patients in Korea. Although the mutation screening was performed in 10 genes that cause IGD, molecular defects were identified in relatively small proportions of the cohort.
참고문헌 (40)
- Bianco SD, "The genetic and molecular basis of idiopathic hypogonadotropic hypogonadism", Nat Rev Endocrinol, 5, pp.569~576 (2009)
- Laitinen EM, "Incidence, phenotypic features and molecular genetics of Kallmann syndrome in Finland", Orphanet J Rare Dis, 6, pp.41~ (2011)
- Seminara SB, "Gonadotropinreleasing hormone deficiency in the human (idiopathic hypogonadotropic hypogonadism and Kallmann's syndrome): pathophysiological and genetic considerations", Endocr Rev, 19, pp.521~539 (1998)
- Schwanzel-Fukuda M, "Luteinizing hormone-releasing hormone (LHRH)-expressing cells do not migrate normally in an inherited hypogonadal (Kallmann) syndrome", Brain Res Mol Brain Res, 6, pp.311~326 (1989)
- Tobet SA, "Developmental aspect of the gonadotropin-releasing hormone system", Mol Cell Endocrinol, 185, pp.173~184 (2001)
- Kaplan JD, "Clues to an early diagnosis of Kallmann syndrome", Am J Med Genet A, 152A, pp.2796~2801 (2010)
- Semple RK, "The recent genetics of hypogonadotrophic hypogonadism - novel insights and new questions", Clin Endocrinol (Oxf), 72, pp.427~435 (2010)
- Hayes FJ, "Hypogonadotropic hypogonadism", Endocrinol Metab Clin North Am, 27, pp.739~763 (1998)
- Quaynor SD, "The prevalence of digenic mutations in patients with normosmic hypogonadotropic hypogonadism and Kallmann syndrome", Fertil Steril, 96, pp.1424.e6~1430.e6 (2011)
- Layman LC., "Genetic diagosis of endocrine disorders", pp.217~225 (2010), Academic Press
- Oliveira LM, "The importance of autosomal genes in Kallmann syndrome: genotype-phenotype correlations and neuroendocrine characteristics", J Clin Endocrinol Metab, 86, pp.1532~1538 (2001)
- Balasubramanian R, "Isolated GnRH deficiency: a disease model serving as a unique prism into the systems biology of the GnRH neuronal network", Mol Cell Endocrinol, 346, pp.4~12 (2011)
- Fraietta R, "Hypogonadotropic hypogonadism revisited", Clinics (Sao Paulo), 68(Suppl 1), pp.81~88 (2013)
- Marshall WA, "Variations in the pattern of pubertal changes in boys", Arch Dis Child, 45, pp.13~23 (1970)
- Schonfeld WA., "Primary and secondary sexual characteristics:study of their development in males from birth through maturity, with biometric study of penis and testes", Am J Dis Child, 65, pp.535~549 (1943)
- Feldman KW, "Fetal phallic growth and penile standards for newborn male infants", J Pediatr, 86, pp.395~398 (1975)
- Greulich WW, "Radiographic atlas of skeletal development of the hand and wrist" (1959), Stanford University Press
- An SY, "Analysis of the correctanswer rate of the odor identification test in KVSS (Korean Version of Sniffin’ Sticks) test", Rhinology, 50, pp.1109~1113 (2007)
- Sykiotis GP, "Oligogenic basis of isolated gonadotropin-releasing hormone deficiency", Proc Natl Acad Sci U S A, 107, pp.15140~15144 (2010)
- Pingault V, "Loss-of-function mutations in SOX10cause Kallmann syndrome with deafness", Am J Hum Genet, 92, pp.707~724 (2013)
- Jongmans MC, "CHD7mutations in patients initially diagnosed with Kallmann syndrome: the clinical overlap with CHARGE syndrome", Clin Genet, 75, pp.65~71 (2009)
- Chaoui A, "Identification and functional analysis of SOX10 missense mutations in different subtypes of Waardenburg syndrome", Hum Mutat, 32, pp.1436~1449 (2011)
- Verloes A., "Updated diagnostic criteria for CHARGE syndrome: a proposal", Am J Med Genet A, 133A, pp.306~308 (2005)
- Viswanathan V, "Etiology and treatment of hypogonadism in adolescents", Pediatr Clin North Am, 58, pp.1181~1200 (2011)
- Cadman SM, "Molecular pathogenesis of Kallmann's syndrome", Horm Res, 67, pp.231~242 (2007)
- Schwanzel-Fukuda M., "Origin and migration of luteinizing hormone-releasing hormone neurons in mammals", Microsc Res Tech, 44, pp.2~10 (1999)
- Dode C, "Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome", Nat Genet, 33, pp.463~465 (2003)
- Gurbuz F, "Distribution of gene mutations associated with familial normosmic idiopathic hypogonadotropic hypogonadism", J Clin Res Pediatr Endocrinol, 4, pp.121~126 (2012)
- Cortez AB, "Congenital heart disease associated with sporadic Kallmann syndrome", Am J Med Genet, 46, pp.551~554 (1993)
- Abujbara MA, "Clinical and inheritance profiles of Kallmann syndrome in Jordan", Reprod Health, 1, pp.5~ (2004)
- Lieblich JM, "Syndrome of anosmia with hypogonadotropic hypogonadism (Kallmann syndrome): clinical and laboratory studies in 23 cases", Am J Med, 73, pp.506~519 (1982)
- Bardin CW, "Studies of the pituitary-Leydig cell axis in young men with hypogonadotropic hypogonadism and hyposmia:comparison with normal men, prepuberal boys, and hypopituitary patients", J Clin Invest, 48, pp.2046~2056 (1969)
- Quinton R, "Idiopathic gonadotrophin deficiency:genetic questions addressed through phenotypic characterization", Clin Endocrinol (Oxf), 55, pp.163~174 (2001)
- Duprez TP, "Imaging the olfactory tract (cranial nerve #1)", Eur J Radiol, 74, pp.288~298 (2010)
- Warner MD, "Olfactory deficits and Down's syndrome", Biol Psychiatry, 23, pp.836~839 (1988)
- Zaghouani H, "Kallmann syndrome: MRI findings", Indian J Endocrinol Metab, 17(Suppl 1), pp.S142~S145 (2013)
- Koenigkam-Santos M, "Quantitative magnetic resonance imaging evaluation of the olfactory system in Kallmann syndrome: correlation with a clinical smell test", Neuroendocrinology, 94, pp.209~217 (2011)
- Hoffman AR, "Induction of puberty in men by long-term pulsatile administration of lowdose gonadotropin-releasing hormone", N Engl J Med, 307, pp.1237~1241 (1982)
- Martin KA, "Comparison of exogenous gonadotropins and pulsatile gonadotropin-releasing hormone for induction of ovulation in hypogonadotropic amenorrhea", J Clin Endocrinol Metab, 77, pp.125~129 (1993)
- Han TS, "What is the optimal therapy for young males with hypogonadotropic hypogonadism?", Clin Endocrinol (Oxf), 72, pp.731~737 (2010)